BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17193947)

  • 1. Nursing considerations for clofarabine in the treatment of acute lymphoblastic leukemia in children.
    McDonald LR; McCarthy CH
    Clin J Oncol Nurs; 2006 Dec; 10(6):809-15. PubMed ID: 17193947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clofarabine in pediatric acute leukemia: current findings and issues.
    Hijiya N; Barry E; Arceci RJ
    Pediatr Blood Cancer; 2012 Sep; 59(3):417-22. PubMed ID: 22354543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nursing considerations for optimal outpatient management of adult patients with leukemia treated with clofarabine.
    Dressel A; Kwari M; McGreal AM
    Clin J Oncol Nurs; 2011 Feb; 15(1):E13-23. PubMed ID: 21278032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clofarabine induced durable complete remission in heavily pretreated adolescents with relapsed and refractory leukemia.
    Steinherz PG; Meyers PA; Steinherz LJ; Jeha S
    J Pediatr Hematol Oncol; 2007 Sep; 29(9):656-8. PubMed ID: 17805046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic effect of clofarabine in children with relapsed or refractory acute lymphoblastic leukemia].
    Suo P; Zhang LP; Wu J; Lu AD; Wang B; Zuo YX; Cheng YF; Liu GL
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jun; 15(6):444-7. PubMed ID: 23791059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clofarabine for the treatment of acute lymphoblastic leukemia.
    Jeha S; Kantarjian H
    Expert Rev Anticancer Ther; 2007 Feb; 7(2):113-8. PubMed ID: 17288522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clofarabine-induced capillary leak syndrome in a child with refractory acute lymphoblastic leukemia.
    Baytan B; Ozdemir O; Gunes AM; Dönmez O
    J Pediatr Hematol Oncol; 2010 Mar; 32(2):144-6. PubMed ID: 20057324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remission re-induction chemotherapy with clofarabine, topotecan, thiotepa, and vinorelbine for patients with relapsed or refractory leukemia.
    Steinherz PG; Shukla N; Kobos R; Steinherz L
    Pediatr Blood Cancer; 2010 May; 54(5):687-93. PubMed ID: 20205253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent progress in the treatment of acute lymphoblastic leukemia: clofarabine.
    Jeha S
    Hematol Oncol Clin North Am; 2009 Oct; 23(5):1137-44, viii. PubMed ID: 19825457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal skin and liver toxicity in a patient treated with clofarabine.
    Johnston DL; Mandel KM
    Pediatr Blood Cancer; 2008 May; 50(5):1082. PubMed ID: 17957757
    [No Abstract]   [Full Text] [Related]  

  • 11. Discovery and development of clofarabine: a nucleoside analogue for treating cancer.
    Bonate PL; Arthaud L; Cantrell WR; Stephenson K; Secrist JA; Weitman S
    Nat Rev Drug Discov; 2006 Oct; 5(10):855-63. PubMed ID: 17016426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy, safety and pharmacokinetics of clofarabine in Chinese pediatric patients with refractory or relapsed acute lymphoblastic leukemia: a phase II, multi-center study.
    Lu A; Fang Y; Du X; Li Y; Cai Z; Yu K; Zhao L; Wang B; Wu J; Cheng Y; Zuo Y; Jia Y; Tan F; Ding L; Lu J; Zhang L; Huang X
    Blood Cancer J; 2016 Feb; 6(2):e400. PubMed ID: 26918364
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of higher dose clofarabine in adults with relapsed acute lymphoblastic leukemia.
    McGregor BA; Brown AW; Osswald MB; Savona MR
    Am J Hematol; 2009 Apr; 84(4):228-30. PubMed ID: 19260120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia.
    Jeha S; Gaynon PS; Razzouk BI; Franklin J; Kadota R; Shen V; Luchtman-Jones L; Rytting M; Bomgaars LR; Rheingold S; Ritchey K; Albano E; Arceci RJ; Goldman S; Griffin T; Altman A; Gordon B; Steinherz L; Weitman S; Steinherz P
    J Clin Oncol; 2006 Apr; 24(12):1917-23. PubMed ID: 16622268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clofarabine and nelarabine: two new purine nucleoside analogs.
    Gandhi V; Plunkett W
    Curr Opin Oncol; 2006 Nov; 18(6):584-90. PubMed ID: 16988579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clofarabine for treatment of acute lymphoblastic leukaemia in adults.
    Rodríguez Vargas B; Sánchez Cuervo M; Bermejo Vicedo T
    Farm Hosp; 2011; 35(1):47-9. PubMed ID: 20673734
    [No Abstract]   [Full Text] [Related]  

  • 17. Clofarabine for the treatment of adult acute lymphoid leukemia: the Group for Research on Adult Acute Lymphoblastic Leukemia intergroup.
    Huguet F; Leguay T; Raffoux E; Rousselot P; Vey N; Pigneux A; Ifrah N; Dombret H
    Leuk Lymphoma; 2015 Apr; 56(4):847-57. PubMed ID: 24996442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clofarabine: a size that fits all, may not fit all.
    Vij R
    Leuk Lymphoma; 2009 Mar; 50(3):309-10. PubMed ID: 19347718
    [No Abstract]   [Full Text] [Related]  

  • 19. Early UK experience in the use of clofarabine in the treatment of relapsed and refractory paediatric acute lymphoblastic leukaemia.
    O'Connor D; Sibson K; Caswell M; Connor P; Cummins M; Mitchell C; Motwani J; Taj M; Vora A; Wynn R; Kearns PR
    Br J Haematol; 2011 Aug; 154(4):482-5. PubMed ID: 21689087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clofarabine in the treatment of acute myeloid leukaemia and acute lymphoblastic leukaemia: a review.
    Kline JP; Larson RA
    Expert Opin Pharmacother; 2005 Dec; 6(15):2711-8. PubMed ID: 16316309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.